Venous thromboembolism events among RA patients.
Ribhi Mansour,Shir Azrielant,Shir Azrielant,Abdulla Watad,Abdulla Watad,Shmuel Tiosano,Shmuel Tiosano,Yarden Yavne,Yarden Yavne,Doron Comaneshter,Arnon D. Cohen,Arnon D. Cohen,Howard Amital,Howard Amital +13 more
- Vol. 30, Iss: 1, pp 38-43
Reads0
Chats0
TLDR
RA and mean C-reactive protein levels were found to be independently associated with the proportion of venous thromboembolic events and Physicians should be aware of such findings and have a lower threshold for suspecting detecting such events in patients with RA.Abstract:
Background Rheumatoid arthritis (RA) is associated with an increased risk for venous thromboembolism. However, so far, relatively few and small size-based studies have been conducted. We aimed to investigate the link between RA and venous thromboembolism utilizing a large sample of subjects originating from a large data base. Materials and methods The study was performed utilizing the medical database of Clalit Health Services, the largest healthcare provider in Israel. We enrolled all patients with RA and age- and gender-matched controls. Chi-square and t-tests were used for univariate analysis and a logistic regression model was used for a multivariate analysis. RA patients were compared to controls regarding the proportion of venous thromboembolic events (defined as deep vein thrombosis, pulmonary embolism or both). Multivariate logistic regression was employed to assess factors associated with thromboembolic events. Results The study included 11,782 patients with RA and 57,973 age- and gender-matched controls. RA patients had a higher rate of venous thromboembolism events compared with controls (6.92% vs. 3.18%, respectively, p<0.001). RA and mean C-reactive protein levels were found to be independently associated with the proportion of thromboembolic events (OR 2.27 for RA and 1.07 for each 1 mg/dL increment of mean C-reactive protein, respectively). Conclusion RA and C-reactive protein levels are independently associated with venous thromboembolic events. Physicians should be aware of such findings and have a lower threshold for suspecting detecting such events in patients with RA, mainly those with mean high levels of C-reactive protein.read more
Citations
More filters
Journal ArticleDOI
Cerebrovascular Events in Systemic Lupus Erythematosus: Diagnosis and Management.
TL;DR: Doctors need to educate lupus patients and their families for the early recognition of the signs of stroke and the need to seek prompt attention, and acronyms, such as FAST, can be used as a mnemonic to help detect and enhance responsiveness to the needs of a person having a stroke.
Journal ArticleDOI
Risk of venous thromboembolism in immune-mediated inflammatory diseases: a UK matched cohort study.
James Galloway,Kevin Barrett,Peter M. Irving,Kaivan Khavandi,Monica Nijher,Ruth Nicholson,Simon de Lusignan,Simon de Lusignan,Maya H Buch +8 more
TL;DR: VTE risk is increased in people with IMIDs, and routinely available clinical information may be helpful to identify individuals with an IMID at increased future risk of VTE.
Journal ArticleDOI
Focus on Sex and Gender: What We Need to Know in the Management of Rheumatoid Arthritis
TL;DR: Evaluating how sex and gender can impact current management guidelines and how this issue can be integrated for effective disease control is evaluated.
Journal ArticleDOI
From Rheumatology 1.0 to Rheumatology 4.0 and beyond: the contributions of Big Data to the field of rheumatology.
TL;DR: This paper aims to demonstrate the efforts towards in-situ applicability of EMMARM, as to provide real-time information about the response of the immune system to various types of injuries.
Journal ArticleDOI
Venous Thromboembolism in Rheumatoid Arthritis: The Added Effect of Disease Activity to Traditional Risk Factors
TL;DR: In this paper , the authors reviewed the risk of venous thromboembolism (VTE) in rheumatoid arthritis patients and developed a conceptual framework that describes the interaction between these factors.
References
More filters
Journal ArticleDOI
The pathogenesis of rheumatoid arthritis.
Iain B. McInnes,Georg Schett +1 more
TL;DR: The increased understanding of the immune mechanisms of rheumatoid arthritis has led to the development of a considerable number of new therapeutic agents that alter the natural history of the disease and reduce mortality.
Journal ArticleDOI
Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences
TL;DR: Differences in incidence across age, time, and geographic region suggest that environmental factors significantly modify the expression of Crohn's disease and ulcerative colitis.
2012 Revised International Chapel Hill Consensus Conference Nomenclature of
John Charles Jennette,Ronald Falk,Neil Basu,Maria C. Cid,Franco Ferrario,Luis Felipe Flores-Suárez,W. L. Gross,Loïc Guillevin,E. C. Hagen,Peter Lamprecht,Raashid Luqmani,Seza Ozen,Andrew J. Rees,Scott Dgi,Ulrich Specks,Kei Takahashi,Richard A. Watts +16 more
TL;DR: In this article, the running head is assigned to one of the following candidates:Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, Ferrardo F, Flores-Suarez LF, Gross WL, Guillevin L, Hagen EC, Hoffman GS, Jayne DR, Kallenberg CGM, Lamprecht P, Langford CA, Luqmani RA, Mahr AD, Matteson EL, Merkel PA, Ozen S, Pusey CD, Rasmussen N, Rees
Journal ArticleDOI
Platelet Activation and Atherothrombosis
Giovanni Davì,Carlo Patrono +1 more
TL;DR: This review of the role of platelets in at Herothrombosis illuminates the surprisingly numerous activities of these tiny, anucleate cells and stresses their participation in the inflammatory component of atherothromBosis.